Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma

Head and Neck

Volumn 29, Issue 3, 2007, Pages 203-210

  Jeong, Han Sin ^a   Baek, Chung Hwan ^a   Son, Young Ik ^a   Chung, Man Ki ^a   Lee, Dong Kyung ^a   Choi, Joon Young ^a   Kim, Byung Tae ^a   Kim, Hyung Jin ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Computed tomography; Head and neck neoplasms; Positron emission tomography; Squamous cell carcinoma; Tumor staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPROMIDE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; IMAGING SYSTEM; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; WHOLE BODY SCANNER; AGED; HEAD AND NECK TUMOR; LYMPH NODE; METHODOLOGY; MIDDLE AGED; NECK; PATHOLOGY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; MIDDLE AGED; NECK; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33847363932     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20504     Document Type: Article

References (15)

1. Adams S, Baum RP, Stuckensen T, Bitter K, Hor G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255-1260.
2. Braams JW, Pruim J, Freling NJ, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211-216.
3. Hannah A, Scott AM, Tochon-Danguy H, et al. Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer. Ann Surg 2002;236:208-217.
4. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747-1757.
5. McGuirt WF, Williams DW III, Keyes JW Jr, et al. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995;105:373-375.
6. Hanasono MM, Kunda LD, Segall GM, Ku GH, Terris DJ. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880-885.
7. Antoch G, Saoudi N, Kuehl H, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 2004;22:4357-4368.
8. Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 2002;225:575-581.
9. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507.
10. Schoder H, Yeung HW, Gonen M, Kraus D, Larson SM. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 2004;231:65-72.
11. Greene FL, Page DL, Fleming ID, et al, editors. AJCC cancer staging manual, 6th ed. New York: Springer-Verlag; 2002.
12. Lee EJ, Choi JY, Choi Y, et al. Improvement in the differentiation of malignant nodes from benign nodes preoperatively in non-small cell lung cancer (NSCLC) using FDG PET/CT [abstract]. J Nucl Med 2004;45:374P.
13. Som PM. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 1992;158:961-969.
14. Choi JY, Lee EJ, Chung HW, et al. Usefulness of FDG PET/CT to detect double primary malignancies in oncologic patients [abstract]. J Nucl Med 2004;45:368P.
15. 18F] fluorodeoxyglucose positron emission tomography and computed tomography for initial tumor staging. J Clin Oncol 2005;23:7654-7659.